4//SEC Filing
HANTSON LUDWIG 4
Accession 0000899866-21-000058
CIK 0000899866other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:56 PM ET
Size
6.7 KB
Accession
0000899866-21-000058
Insider Transaction Report
Form 4
HANTSON LUDWIG
DirectorCEO
Transactions
- Award
Common Stock, par value $.0001 per share
2021-07-14+120,894→ 470,060 total - Award
Common Stock, par value $.0001 per share
2021-07-14+119,847→ 589,907 total
Footnotes (2)
- [F1]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan.
- [F2]On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan.
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001491435
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 4:56 PM ET
- Size
- 6.7 KB